about
From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemiaItraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonistsRole of endoplasmic reticulum stress in drug-induced toxicityEpigenetic changes during cell transformationArsenic-mediated activation of the Nrf2-Keap1 antioxidant pathwayArsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6Arsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligaseCurrent developments in toxicological research on arsenicAdministration of zinc against arsenic-induced nephrotoxicity during gestation and lactation in rat modelAcute kidney injury from different poisonous substances.Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancersSodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC)Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment.Pathways of arsenic uptake and efflux.Silencing SATB1 inhibits the malignant phenotype and increases sensitivity of human osteosarcoma U2OS cells to arsenic trioxide.Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell linesArsenic: a potentially useful poison for Hedgehog-driven cancers.Expression of AFP and STAT3 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in AFP-producing gastric cancer cellsArsenic sulfide as a potential anti‑cancer drug.Resveratrol protects against arsenic trioxide-induced oxidative damage through maintenance of glutathione homeostasis and inhibition of apoptotic progression.Tetramethylpyrazine (TMP) protects against sodium arsenite-induced nephrotoxicity by suppressing ROS production, mitochondrial dysfunction, pro-inflammatory signaling pathways and programed cell death.Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.Arsenic Trioxide Activate Transcription of Heme Oxygenase-1 by Promoting Nuclear Translocation of NFE2L2.Arsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer.A metabolic prosurvival role for PML in breast cancer.Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth.Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxideDeficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancerThe Coadministration of N-Acetylcysteine Ameliorates the Effects of Arsenic Trioxide on the Male Mouse Genital System.Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53.Arsenic suppresses cell survival via Pirh2-mediated proteasomal degradation of ΔNp63 protein.Arsenic Trioxide as a Vascular Disrupting Agent: Synergistic Effect with Irinotecan on Tumor Growth Delay in a CT26 Allograft Model.Treatment of acute promyelocytic leukemia for older patients.Chronic arsenic trioxide exposure leads to enhanced aggressiveness via Met oncogene addiction in cancer cells.Arsenic trioxide inhibits lung metastasis of mouse colon cancer via reducing the infiltration of regulatory T cells.Arsenic trioxide and other arsenical compounds inhibit the NLRP1, NLRP3, and NAIP5/NLRC4 inflammasomes.Nephroprotective effect of astaxanthin against trivalent inorganic arsenic-induced renal injury in wistar rats.Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9Chronic myeloid leukemia stem cells and developing therapies.
P2860
Q24605527-C441A3CD-F084-47AF-98A4-21D72D49ACCDQ24632161-62C47267-B7CA-4A3A-A97A-8B54C7EEF1A9Q26765518-015C7A88-4D8A-4EE0-AAF9-299C34531D1FQ27002968-027665D1-6AAC-4208-A8E7-0752331FE7E4Q28386384-8A87F19C-D9CF-4AA5-ADDF-87A2596E0963Q28481142-E43EDC31-85DB-4BA5-9063-78AE7418FEFAQ28541801-47E4385C-F8A5-4C36-9DEC-29A2019026EEQ28600941-99023E3E-A447-4593-B332-AFE9576432ACQ33638692-8530F3C3-00F3-4F40-A12A-E338BACE3B5AQ33655416-72BB5384-B791-4D25-99EB-12618523A113Q33768666-98E49C99-EA7E-4338-8C11-17C042A7F1EFQ33940195-DDF12866-40A3-401B-AD41-A9DE4A5056E6Q34260622-A0B34385-FC9A-47AA-952E-1BF875A5BE71Q34304715-5F929011-6BDF-494F-BBF1-125F01A6CB4FQ34334216-3B5AF085-33F1-4A94-8F31-4E49E618E53CQ34410337-477550AE-29CF-43E2-8939-6FA56DAA71FAQ34429067-7927980F-DE6B-4BE4-B19C-517C82347EAEQ34575667-4E97D478-F16A-4535-8F4C-7C74E41C2B38Q34673252-022FE1C2-81EF-4EBC-93ED-C2B62D5DE761Q35224476-D55698A5-ACEC-4703-AF99-58FBCEC428B7Q35226559-F62C5374-0720-459B-9FDD-BCBC711F3641Q35618400-D7D7E26A-9050-412C-BAAF-D8FEEBF7887FQ35942156-47DADDDA-E47C-490B-BD61-CBD6ACA7D51EQ36202278-4EB04836-4E28-4012-B036-A6ABA79001CAQ36208566-3336CBC8-E72F-449B-9D6A-86251A5F6BB1Q36253212-537E81EC-C85C-4002-AC00-DC740E0FB3D0Q36277354-616979EC-C742-4896-A8D4-28AFB72D511EQ36352545-5C0D819F-78B0-40ED-86B7-8F49B2BEB130Q36392876-777E72A1-9223-4AE7-92DF-BAB4F3CA124FQ36453805-E94B341A-5993-42EF-BF0A-6DB633A04A7AQ36500275-4972EDAC-3AEF-41A7-9814-9873206D84FCQ36579412-187D28FF-ADA6-40E1-9006-62738460CB75Q36613318-253C3D62-B6F7-4E34-9378-3596A249BCE5Q36672084-D1029F68-0EF4-4959-B899-11F3A27F9F26Q37317264-ECC62B7B-C5F1-4C9B-A64E-C88DAEE176EAQ37447671-8CE83967-2934-4972-A5A5-7156C7810366Q37449578-DB5D677A-4F6E-4A0D-AD81-4459277644A7Q37620481-52FEDA93-06BB-4443-95B5-C4B0AFEC8CDEQ37696319-2A02800A-0EDC-4B12-857C-E7DCBD418AAEQ37836936-FFB742BD-4E86-45BF-B613-11AE7A37F110
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Arsenic trioxide - An old drug rediscovered.
@ast
Arsenic trioxide - An old drug rediscovered.
@en
Arsenic trioxide - An old drug rediscovered.
@nl
type
label
Arsenic trioxide - An old drug rediscovered.
@ast
Arsenic trioxide - An old drug rediscovered.
@en
Arsenic trioxide - An old drug rediscovered.
@nl
prefLabel
Arsenic trioxide - An old drug rediscovered.
@ast
Arsenic trioxide - An old drug rediscovered.
@en
Arsenic trioxide - An old drug rediscovered.
@nl
P2860
P1433
P1476
Arsenic trioxide - An old drug rediscovered.
@en
P2093
Ashkan Emadi
Steven D Gore
P2860
P304
P356
10.1016/J.BLRE.2010.04.001
P577
2010-05-15T00:00:00Z